Life-Threatening Chemotoxicity

Slides:



Advertisements
Similar presentations
Disease Modifying Anti-Rheumatic Drugs (DMARDs) Immunomodulatory and immunosuppresive Xenobiotic – Gold salts – Azathioprine – Methotrexate Biological.
Advertisements

Applying the Nursing Process to Drug Therapy
Numbers
Concerns in Medication Safety in Regards to the Older Adult Population Stephanie A. Ball, Taylor W. Brickley, Macey F. Davenport, Kelly L. Erexson, Emily.
Polypharmacy and preventing hospital admissions
Grundtvig Learning Partnership Nr. LLP-GRU-MP-2013-LT Improving Participation in Adult Education Adult education provision in Lithuania.
Conclusions. Conclusions -In patients undergoing primary angioplasty, prophylactic treatment with N-acetylcysteine seems to reduce the rate of contrast-medium.
LOCAL PASS A Local approach towards the reduction of PsychoActive Substance uSe Renée Otte February 5, 2015.
Developing a specialist community based service for adolescent drug users Jack Leach Consultant in substance misuse Young persons drug project, Bolton.
Text Dependent Questions.  How is the teen brain like a car without brakes? Question 1.
© TANUVAS, 2011 Veterinary medical records. Veterinary medical records Introduction  Veterinary medical records meant to provide necessary information.
10-1 人生与责任 淮安工业园区实验学校 连芳芳 “ 自我介绍 ” “ 自我介绍 ” 儿童时期的我.
Introduction Results Method Conclusions
Pembrolizumab Drugbank ID :DB09037 Half life : 28 days.
Muscle pain with taking statin
INTRODUCTION The oral route of drugs administration is the most important method of administering drugs for systemic effects.
Yahoo Mail Customer Support Number
Most Effective Techniques to Park your Manual Transmission Car
How do Power Car Windows Ensure Occupants Safety
Medication Effects That May Impair Driving Ability
Managing Women Living With HIV Infection
Materials & Methods Introduction Abstract Results Conclusion
Addressing Cognitive and Psychiatric Effects of Antiepileptic Drugs
مبررات إدخال الحاسوب في رياض الأطفال
Appropriate Stroke Prevention Strategies in Atrial Fibrillation
Optimizing Outcomes With CT Imaging
CDT Porto Dissuasion Intervention, Priority Groups
Definitions: Seizure, Epilepsy, Epilepsy Syndrome
Management Considerations in Epilepsy Among Long-Term Care Residents
Understanding Statin Metabolism
Emergency Drug Therapy
Oral Anticoagulants in AFa,b A Brief History.
Selecting NOACs for High-Risk Patients
Tubulointerstitial Injury Associated With Chemotherapeutic Agents
How to Adjust Anticoagulant Dosing
MDS: Introduction. Supportive Care in the Treatment of Lower-Risk Myelodysplastic Syndromes.
Overview. Maximizing the Safety of CAR T-Cell Therapy: Prevention, Early Recognition, and Management.
Advances in the Management of Severe and Life-Threatening Chemotoxicity.
Early Detection and Treatment
THANK YOU!.
Professional Organizations
Optimizing Outcomes and Managing Adverse Events in CLL
21twelveinteractive.com/ twitter.com/21twelveI/ facebook.com/21twelveinteractive/ linkedin.com/company/21twelve-interactive/ pinterest.com/21twelveinteractive/
Thank you.
Definition of Elderly. Advanced Age and CV Risk: To Start or Not to Start a Statin in Older Patients?
Thank you.
What You Didn't Know About AF and Renal Dysfunction
Individual Variation in Drug Responses
A Nursing Perspective on Improving Outcomes for Patients With Hemophilia.
The Rising Crisis of Prediabetes Diagnosis and Management of the Patient With Prediabetes.
Challenges in LA SCCHN.
Materials & Methods Introduction Abstract Results Conclusion
Perspective on the Multidisciplinary Management of PAH
Materials & Methods Introduction Abstract Results Conclusion
How to Adjust Anticoagulant Dosing
Introduction. Welcome to this program, titled De-Escalating Therapy in Epilepsy: A Return to Monotherapy.
Real-World Data in Cardiology: Focus on Atrial Fibrillation

Drug Therapy in Pediatric Patients
Materials & Methods Introduction Abstract Results Conclusion
Of AIDS cases diagnosed in 2006 among male adults and adolescents, 59% were attributed to male-to-male sexual contact and 16% were attributed to injection.
Materials & Methods Introduction Abstract Results Conclusion
Care Team Collaboration for CAR T-Cell Therapy: Real-World Advice
A1C at baseline, 16 weeks, and 32 weeks according to study group in all participants (A), adult participants (B), and adolescent participants (C) who returned.
Presentation transcript:

Life-Threatening Chemotoxicity

Program Goals

Introduction

Tumor Lysis Syndrome

High-Dose MTX: Paradigm of Life-Threatening Chemotoxicity

HDMTX: Mechanism of Action

Uses of HDMTX

Toxicities Associated With HDMTX

HDMTX Toxicity: Risk Factors

HDMTX: Drug-Drug Interactions

Preventing HDMTX Toxicity

HDMTX: Dosing and Administration

LV Rescue

MTX Clearance

Case 1: Adult

Case 1: Adult (cont)

HDMTX: Management of Toxicity

Case 2: Adolescent

Case 3: Adolescent

Case 3: Adolescent (cont)

Glucarpidase: Mechanism of Action

HDMTX-Induced Renal Dysfunction: Effect of Early Intervention of Glucarpidase + LV

HDMTX: Multidisciplinary Care

HDMTX: Reinitiation After Toxicity

HDMTX: Reinitiation After Toxicity (cont)

Conclusions

Thank you for participating in this activity.